In pancreatic ductal adenocarcinoma, MYC binds to neuroendocrine genes to facilitate ductal-neuroendocrine plasticity and thereby contributes to chemotherapy resistance [23]. This evidence concerns the gene MYC and pancreatic ductal adenocarcinoma.